We highlight four standout examples of collaborations that lie outside of the traditional pharmaceutical-to-pharmaceutical mould, noting innovative campaigns, fast-tracked drug development, and partnerships advocating for vaccine adherence.
HOPELESSLY DEVOTED TO CANCER AWARENESS
Gilead’s Immunomedics have teamed up with Mediaplanet to enlist 80s icon and breast cancer survivor, Olivia Newton-John, for their online breast cancer awareness campaign. The campaign casts a spotlight onto other celebrity survivors of the disease who share their personal stories and experiences in a push to drive awareness of breast cancer beyond its October awareness month.
QUANTUM LEAPS IN R&D
Boehringer Ingelheim has become the first pharma company to team up with tech giant Google for a 3-year venture co-led by their newly established Quantum Lab. The partnership aims to harness quantum computing for research that can accurately simulate and compare large molecules, ultimately accelerating and enhancing drug development in a range of disease areas.
PFIZER’S VACCINE ROAD AHEAD
To combat fear, dispel misconceptions, and provide assurance surrounding COVID-19 vaccines, Pfizer and BioNTech have debuted their awareness campaign produced in coalition with various health and trade organisations. The project features 30-second videos self-shot by members of the public as they reminisce on pre-COVID life. The campaign hopes to encourage adherence and generate confidence in vaccines as mass rollout gains momentum.
AI IMAGING WITH BLACKFORD AND BAYER
In a bid to advance AI-enabled radiology and medical imaging solutions, Bayer have signed an agreement with Blackford Analysis, a Scottish AI specialist company. Their new platform will provide HCPs with access to a ‘virtual marketplace’ and hopes to improve diagnostics as well as aid radiologists in their decision-making.